Preventive Care & Screening Board Prep

Preventive care is the single largest content area on the ABFM. Master the USPSTF grades, ACIP schedule, and cancer screening guidelines.

Preventive care and screening is the largest single content area on the ABFM Family Medicine boards, often making up 13 to 15 percent of the total exam. That weight reflects the central role of prevention in family medicine and the testable concreteness of guideline-based recommendations. The exam draws primarily from three sources: the US Preventive Services Task Force (USPSTF) recommendation statements, the CDC Advisory Committee on Immunization Practices (ACIP) vaccine schedule, and major cancer screening guidelines from the American Cancer Society and specialty societies. Mastering these three references is the highest-leverage studying you can do for the ABFM.

The USPSTF uses a letter grade system that itself is heavily tested. Grade A means recommended with high certainty of substantial benefit. Grade B means recommended with high certainty of moderate benefit, or moderate certainty of moderate-to-substantial benefit. Grade C means individualized — offer or do not offer based on professional judgment. Grade D means do not offer; harms outweigh benefits. Grade I means insufficient evidence. The ABFM tests both the recommendation itself and the grade. Knowing that "low-dose aspirin for primary prevention of cardiovascular disease" is now a Grade C in adults 40 to 59 (and Grade D in adults 60 and older) is the kind of detail that wins points.

Cancer screening is the most concentrated subdomain. Colorectal cancer screening starts at 45 (Grade B). Lung cancer screening with low-dose CT is recommended annually for adults 50 to 80 with at least 20 pack-year smoking history who currently smoke or quit within the last 15 years (Grade B, updated 2021). Breast cancer screening with biennial mammography is Grade B for women 50 to 74, with individualized decisions for 40 to 49 (recently updated to Grade B starting at 40 in 2024). Cervical cancer screening: Pap every 3 years for ages 21 to 29; Pap plus HPV co-test every 5 years (or Pap alone every 3 years, or HPV alone every 5 years) for ages 30 to 65; stop at 65 with adequate prior screening. Prostate cancer screening is Grade C for ages 55 to 69 (shared decision-making) and Grade D for ages 70 and older.

The ACIP vaccine schedule is updated annually and is heavily tested. Recent updates include the 2022 universal hepatitis B vaccination for adults under 60, the 2023 RSV vaccine recommendations (adults 75 and older universally, and 60 to 74 with risk factors), and the 2023 pneumococcal vaccine simplifications (PCV20 alone, or PCV15 followed by PPSV23, in adults 65 and older or with high-risk conditions). Influenza, COVID-19, Tdap, shingles (Shingrix at age 50), and HPV vaccines are all tested annually.

Lifestyle counseling and behavioral interventions also fall under preventive care. The USPSTF recommends behavioral counseling for tobacco cessation, alcohol misuse, healthy diet and physical activity in adults with cardiovascular risk factors, and intensive behavioral counseling for obesity. These appear less often than screening tests but reliably as part of comprehensive prevention questions.

High-yield preventive care & screening topics

• USPSTF aspirin for primary prevention. Adults 40 to 59 with 10-year ASCVD risk over 10 percent: Grade C — individualized. Adults 60 and older: Grade D — do not initiate. The 2022 update reflects new evidence that bleeding risk in older adults often outweighs cardiovascular benefit. Continue aspirin for established ASCVD (secondary prevention).
• Lung cancer screening criteria (USPSTF 2021). Annual low-dose CT for adults 50 to 80 with 20 or more pack-years of smoking who currently smoke or quit within the last 15 years (Grade B). Stop screening when 15 years have passed since quitting, life expectancy is limited, or unable to undergo curative surgery.
• Breast cancer screening (USPSTF 2024 update). Biennial mammography for women 40 to 74 (Grade B, updated from age 50 in 2024). Insufficient evidence for screening at 75 and older. Increased frequency or additional modalities (MRI, ultrasound) for high-risk women per ACS or NCCN criteria.
• Cervical cancer screening. Age 21 to 29: cytology alone every 3 years. Age 30 to 65: cytology alone every 3 years, HPV testing alone every 5 years, or co-testing every 5 years. Stop at 65 with adequate prior screening (3 negative cytology or 2 negative co-tests in past 10 years). Stop after hysterectomy with cervix removal for benign disease.
• Adult immunization highlights (ACIP). Annual flu and COVID-19. Tdap once then Td/Tdap every 10 years. Shingrix at 50. Pneumococcal (PCV20 alone, or PCV15 then PPSV23) at 65 or with risk factors. Hepatitis B universally under 60. HPV through age 26 (catch-up to 45 in some). RSV at 75 and older universally; 60 to 74 with risk factors.
• Diabetes screening. USPSTF Grade B: screen adults 35 to 70 with overweight or obesity. Earlier and more frequent for higher-risk populations. Screen with A1c, fasting glucose, or 2-hour OGTT. Repeat every 3 years if normal, annually for prediabetes.
• AAA screening. One-time abdominal ultrasound for men 65 to 75 who have ever smoked (Grade B). Selectively offer for men 65 to 75 who have never smoked (Grade C). Insufficient evidence for women without smoking history.
• Behavioral counseling interventions. Tobacco cessation: Grade A. Healthy diet and physical activity for adults with cardiovascular risk factors: Grade B. Intensive multicomponent behavioral interventions for obesity (BMI 30 or higher): Grade B. Alcohol misuse screening and brief intervention: Grade B.

ABFM exam tips

Memorize USPSTF grade definitions, not just the recommendations. A and B mean recommend. C means individualize. D means do not offer. I means insufficient evidence. Many questions test whether you know that aspirin in adults 60 and older is Grade D (do not initiate), not Grade B.

Anchor on the recent updates. The exam emphasizes guidelines that have changed in the last 3 to 5 years: colorectal screening starting at 45 (2021), breast screening starting at 40 (2024), aspirin downgrade for older adults (2022), expanded hepatitis B vaccination (2022), updated pneumococcal recommendations (2021 to 2023), and RSV vaccine introduction (2023).

For cancer screening questions, identify the modality first, then frequency, then start and stop ages. Lung cancer screening is annual low-dose CT, ages 50 to 80, with the 20-pack-year and 15-year quit threshold. Breast cancer screening is biennial mammography, ages 40 to 74. Colorectal screening has multiple modalities — know the equivalents.

Know which patients are low-dose aspirin candidates and which are not. Adults 40 to 59 with elevated cardiovascular risk and willing to take it for at least 10 years: Grade C, individualize. Adults 60 and older without ASCVD: do not initiate (Grade D). Patients with established ASCVD: continue (secondary prevention, separate evidence base).

For vaccines, the most testable scenario is "what's missing?" The exam shows a patient's vaccine record and asks what they are due for. Memorize the schedule by age: Shingrix at 50, pneumococcal at 65, RSV at 75, HPV through 26 (or 45), hepatitis B if under 60 and unvaccinated.

Recognize the difference between screening and diagnostic tests. A patient with symptoms is no longer being "screened." If a vignette says "the patient reports a breast lump," the answer is diagnostic mammogram and ultrasound, not screening mammography. The USPSTF recommendations apply to asymptomatic average-risk patients only.

Common pitfalls

Do not recommend low-dose aspirin for primary prevention in adults 60 and older. This was a major 2022 update. The USPSTF moved to Grade D for this age group due to bleeding risk outweighing cardiovascular benefit. Aspirin for established ASCVD (secondary prevention) is unchanged — that is a different recommendation.

Do not start colorectal screening at 50. The 2021 USPSTF update lowered the age to 45 (Grade B). Patients aged 45 to 49 should be offered screening as if they were 50 to 75 average-risk. Older study materials are wrong on this point.

Do not screen for prostate cancer with PSA in men 70 and older. USPSTF Grade D — do not offer. For men 55 to 69, it is Grade C — shared decision-making. Routine PSA screening in men 70 and older is a tested error.

Do not over-screen for cervical cancer in low-risk women. Stopping at age 65 with adequate prior screening (three consecutive negative cytology or two negative co-tests in the past 10 years) is the rule. Continuing screening into 70s and 80s in a patient with consistently negative results is a tested overuse.

Do not skip behavioral counseling questions because they feel "soft." USPSTF behavioral interventions (tobacco cessation, healthy diet and exercise, alcohol screening, obesity counseling) are tested concretely. Tobacco cessation counseling is Grade A and asked in nearly every full exam.

Do not assume vaccine recommendations are stable year to year. ACIP updates the schedule annually, and new vaccines (RSV, expanded pneumococcal) appear regularly. Use the most recent CDC adult immunization schedule. The 2022 hepatitis B universal recommendation under 60 is still missed by many test-takers.

Do not confuse Grade C with Grade D. Grade C means offer with shared decision-making — sometimes the right answer is "discuss with the patient and offer if they choose." Grade D means do not offer. The exam tests this distinction directly, especially with PSA and aspirin.

Frequently asked questions

How much of the ABFM is preventive care?

Preventive care and screening typically makes up 13 to 15 percent of the ABFM exam, making it the single largest content area. That translates to roughly 40 to 45 questions per full exam. USPSTF recommendations and the ACIP vaccine schedule supply the bulk of testable content.

How do USPSTF letter grades work on the boards?

Grade A or B means the service is recommended (offer it). Grade C means individualize based on professional judgment and patient values. Grade D means do not offer because harms outweigh benefits. Grade I means evidence is insufficient. The exam tests both the recommendation and the grade — know both.

What is the most-tested vaccine update?

The 2022 universal hepatitis B vaccination for all adults under 60, the 2023 RSV vaccine recommendations, and the 2021 to 2023 pneumococcal simplifications (PCV20 alone, or PCV15 then PPSV23) are the highest-yield recent updates. Annual influenza and COVID-19 boosters are reliable test items.

When should I screen for lung cancer?

Annual low-dose CT for adults aged 50 to 80 with at least 20 pack-years of smoking who currently smoke or quit within the past 15 years (USPSTF Grade B, 2021 update). Stop screening when 15 years have passed since quitting, life expectancy is limited, or the patient cannot undergo curative surgery.

Has breast cancer screening changed recently?

Yes. The 2024 USPSTF update lowered the recommended start age for biennial mammography from 50 to 40 (Grade B for ages 40 to 74). Insufficient evidence remains for ages 75 and older. This is a frequently tested recent update, and many study materials still reflect the older 50-to-74 recommendation.

How is preventive care different from cancer screening on the boards?

Cancer screening is one subset of preventive care. Preventive care also includes vaccination, behavioral counseling, screening for non-cancer conditions (diabetes, hypertension, hepatitis C, depression, intimate partner violence), and chemoprevention (statins, aspirin in select adults). The ABFM tests all of these.

Should I memorize the entire ACIP schedule?

You do not need every detail, but you should know the adult schedule cold: annual flu and COVID, Tdap with 10-year boosters, Shingrix at 50, pneumococcal at 65 (or earlier with risk), hepatitis B universally under 60, HPV through 26 (with shared decision-making 27 to 45), and RSV at 75 (and 60 to 74 with risk). Special populations (pregnancy, immunocompromise) add layers but follow predictable rules.